Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evogliptin in Type 2 Diabetes Mellitus (Extension Study)
NCT01634282Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Aug 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DA5221-B2 in type 2 diabetes mellitus (T2DM), sponsored by Kyowa Kirin. Started Aug 2009; status: completed.
02
Drugs
DA5221-B2
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01634282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01634282.